Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (111-120 of 366) with videos related to

Pageof 37
Sort By:
American Journal of Clinical Oncology|January 1, 1991
Hemopoietins in clinical oncologyL Kanz, A Lindemann, W Oster, et al.
Seminars in Oncology|February 1, 1995
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancerW Brugger, H Frommhold, K Pressler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Immunoscintigraphy of bone marrow in plasmacytoma]J Bathmann, W Brugger, C Ullrich, et al.
Behring Institute Mitteilungen|August 1, 1988
Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cellsW Oster, A Lindemann, A Ganser, et al.
European Journal of Immunology|March 1, 1988
Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cellsA Lindemann, D Riedel, W Oster, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2M Engelhardt, K Wirth, R Mertelsmann, et al.
Arzneimittel-Forschung|January 1, 1985
Interleukin 2: a reviewJ E Kolitz, K Welte, K W Sykora, et al.
Cellular Immunology|March 1, 1984
Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2V J Merluzzi, D M Savage, R Mertelsmann, et al.
Leukemia|August 1, 1994
Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL)W Digel, J Schultze, R Kunzmann, et al.
Hematology and Cell Therapy|April 1, 1997
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with second primary malignanciesS Fetscher, J Finke, R Engelhardt, et al.
Pageof 37

Showing results (111-120 of 366) with videos related to

Sort By:
Pageof 37
American Journal of Clinical Oncology|January 1, 1991
Hemopoietins in clinical oncologyL Kanz, A Lindemann, W Oster, et al.
Seminars in Oncology|February 1, 1995
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancerW Brugger, H Frommhold, K Pressler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Immunoscintigraphy of bone marrow in plasmacytoma]J Bathmann, W Brugger, C Ullrich, et al.
Behring Institute Mitteilungen|August 1, 1988
Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cellsW Oster, A Lindemann, A Ganser, et al.
European Journal of Immunology|March 1, 1988
Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cellsA Lindemann, D Riedel, W Oster, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2M Engelhardt, K Wirth, R Mertelsmann, et al.
Arzneimittel-Forschung|January 1, 1985
Interleukin 2: a reviewJ E Kolitz, K Welte, K W Sykora, et al.
Cellular Immunology|March 1, 1984
Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2V J Merluzzi, D M Savage, R Mertelsmann, et al.
Leukemia|August 1, 1994
Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL)W Digel, J Schultze, R Kunzmann, et al.
Hematology and Cell Therapy|April 1, 1997
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with second primary malignanciesS Fetscher, J Finke, R Engelhardt, et al.
Pageof 37